WASHINGTON (AP) – U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children 6 months to 5 years old.
That’s according to a person familiar with the matter who spoke on the condition of anonymity to discuss sensitive regulatory issues.
The Biden administration aims to clear the way for the shots as soon as late February.
The company’s application was expected to be submitted as soon as Tuesday. Early Pfizer data has shown the vaccine–which is administered to younger kids at one-tenth the strength of the adult shot–is safe and produces an immune response.
By Zeke Miller, Associated Press
About Brendan Fitzpatrick
